According to The Insight Partners' research, the Europe Companion Animal Diagnostics Market was valued at US$ 1,207.4 Million in 2024 and is expected to reach US$ 2,267.4 Million by 2031, registering a CAGR of 9.5% from 2025 to 2031.
Growing pet humanization and ownership and rising number of strategic initiatives are among the critical factors attributed to the Europe companion animal diagnostics market expansion.
The humanization of pets is growing, and the global population is reshaping the veterinary healthcare landscape. Pet owners are increasingly willing to pay for their pets' health, boosting the demand for accurate and minimally invasive diagnostic solutions.
Companies of animals are highly prone to infectious and chronic diseases that need an early diagnosis. Several references highlight the growing adoption of dogs and their related expenditure on healthcare services. The pet industry is comprehensive, and the demand for companion animal diagnostic products is expected to increase during the forecast period. According to HealthforAnimals' report, over two million people adopted pets during the UK's pandemic lockdowns, while in Australia, over a million pets were adopted during the pandemic. Moreover, families in the US, EU, and China have adopted more than half a billion dogs and cats. Recently, dogs have been the most popular pets in around one in three homes. Nearly a quarter of pet owners have a cat. Demographic changes, rising income levels, and the COVID-19 pandemic have increased the number of people adopting pets.
Pet owners in well-developed economies seek protection against the escalating veterinary treatment costs by applying for a pet insurance policy. In countries such as Sweden and the UK, the penetration rate of pet humanization and ownership is very high, usually at a rate that covers significant numbers of pets under insurance plans. Although the penetration rate of pet ownership in the US and Canada is lower compared to some European countries, its growth trend is progressive and fueled by increased awareness of the significance of pet insurance, coupled with humanization. Owners are much more likely to agree to diagnostic testing despite being unaffordable. This mainly occurs in POC diagnostics, which have the added benefit of delivering rapid results
It makes pet owners more proactive about preventing health concerns. Routine checkups and the early detection of possible health issues have become standard practice, increasing the demand for veterinary POC diagnostic tools that would be applied during routine visits for early-stage condition detection. Thus, growing pet ownership and their humanization boost the companion animal diagnostics market growth.
On the contrary, the high cost of diagnostic products and infrastructure hampers the growth of Europe companion animal diagnostics market.
Europe Companion Animal Diagnostics Market Segmentation Analysis:
- By Product, the Europe Companion Animal Diagnostics Market is segmented into Consumables and Instruments. The Consumables segment is projected to expand at 9.8% CAGR during 2025 - 2031.
- By Companion Animal, the Europe Companion Animal Diagnostics Market is segmented into Dogs, Cats, Horses, and Others. The Dogs segment is projected to expand at 9.9% CAGR during 2025 - 2031.
- By Technology, the Europe Companion Animal Diagnostics Market is segmented into Immunodiagnostics, Molecular Diagnostics, Clinical Biochemistry, Hematology, Urinalysis, and Others. The Immunodiagnostics segment is projected to expand at 10.3% CAGR during 2025 - 2031.
- By Application, the Europe Companion Animal Diagnostics Market is segmented into Clinical Pathology, Bacteriology, Parasitology, Virology, and Others. The Clinical Pathology segment is projected to expand at 10.1% CAGR during 2025 - 2031.
- By End Users, the Europe Companion Animal Diagnostics Market is segmented into Diagnostic and Reference Laboratories, Veterinary Hospitals and Clinics, Research Institutes, and Others. The Veterinary Hospitals and Clinics segment is projected to expand at 9.7% CAGR during 2025 - 2031.
By country, the Europe Companion Animal Diagnostics Market is categorized into Germany, France, the United Kingdom, Italy, Spain, and the Rest of Europe. Germany is projected to expand at 10.3% CAGR during 2025 - 2031.
Key players operating in the Companion Animal Diagnostics Market are Zoetis Inc, Idexx Laboratories Inc, Innovative Diagnostics SAS, Tianjin LOCMEDT Technologies Co Ltd, ARI Medical Technology Co Ltd, and Demeditec Diagnostics GmbH, among others.
- In October 2024, Zoetis, a global leader in animal health, announced the launch of Protivity, the UK and World's first modified-live vaccine for Mycoplasma bovis (M. bovis) in cattle -a research and development achievement decades in the making. Protivity is a modified-live vaccine for M. bovis specifically designed to stimulate the required cell-mediated immune response in beef and dairy calves. This immune response is crucial for optimum protection against M. bovis, as experience shows colostral IgG antibodies alone may fail to protect calves adequately against M.bovis.
- In June 2025, Demeditec Diagnostics GmbH launched their latest quantitative Progesterone camel ELISA (DEV8833) is specially developed for measuring progesterone in camel. With the highest sensitivity and precision, it supports veterinarians, researchers and breeders in diagnosing pregnancy.
Contact Us
Phone: +1-646-491-9876
Email Id: sales@theinsightpartners.com